Daily non-political popular news in brief.

Hypnosis reduces pain and costs in breast cancer surgery

The use of hypnosis prior to breast cancer surgery reduced the amount of anesthesia administered during the operation, the level of pain reported afterwards, and the time and cost of the procedure, according to a study published online Aug. 28 in the Journal of the National Cancer Institute.

Read more »

Keywords: hypnosis, pain, costs, breast, cancer, surgery, hypnosi, cost

« Previous | Next »

Similar news on "Hypnosis reduces pain and costs in breast cancer surgery":

1. Disparities in breast cancer treatment shown for women with disabilities
   11-06-2006 · EurekAlert!
   Among women receiving treatment for early-stage breast cancer, patients with disabilities had higher breast cancer mortality rates and were less likely than other women to receive standard treatment following breast-conserving surgery, according to a study in the November 7 issue of the Annals of Internal Medicine.
   Similar news · Read more »
   
2. Gene patenting -- steep cost for health care and patients
   05-07-2007 · EurekAlert!
   The drug trastuzumab (Herceptin) is used to treat HER2-positive breast cancer (a type of breast cancer that overexpresses the HER2 gene and accounts for about 25 percent of all breast cancers). Trastuzumab therapy improves the chances of survival; however, it has deleterious side effects and is expensive. Thus, it is important to accurately determine the patient's HER2 status.
   Similar news · Read more »
   
3. New adjuvant treatments for breast cancer prove cost-effective
   06-25-2007 · EurekAlert!
   New adjuvant treatments for breast cancer are cost-effective at improving survival, according to two new studies.
   Similar news · Read more »
   
4. Order of chemotherapy, radiation has no effect on breast cancer survival
   10-30-2006 · EurekAlert!
   For women who have had surgery for early breast cancer, it may not matter whether they receive follow-up chemotherapy before, after or during radiation therapy, according to a new review of studies.
   Similar news · Read more »
   
5. Tip sheet Annals of Internal Medicine, Nov. 7, 2006
   11-06-2006 · EurekAlert!
   This Annals of Internal Medicine tip sheet, Nov. 7, 2006, issue includes: Breast cancer patients with disabilities less likely to get breast-conserving surgery; When to stop screening for colorectal cancer? New study says no need to screen older people with three or more chronic diseases; and Review finds inhaled insulin is OK for certain patients but needs long-term study.
   Similar news · Read more »
   
6. A black and white look at breast cancer mortality
   02-21-2007 · EurekAlert!
   Researchers suggest a reason for racial disparity in breast cancer survival rates. African and African American women are much less likely to survive breast cancer surgery than their white counterparts and far more likely to get the disease before the menopause. Previous research suggests that those who undergo surgery for the disease before the menopause are more prone to relapse.
   Similar news · Read more »
   
7. Chemotherapy more effective when given before breast cancer surgery
   05-10-2007 · EurekAlert!
   Giving chemotherapy to women with operable breast cancer before they have surgery -- not after -- helps physicians pin down the best treatment regimen and can reduce the extent of surgery, according to a new systematic review.
   Similar news · Read more »
   
8. Extra radiation dose prevents breast cancer return in young women
   10-29-2007 · EurekAlert!
   Women 40 years and younger with early-stage breast cancer who receive an additional high dose of radiation after undergoing breast-conserving surgery and standard radiation treatment are almost twice as likely to be free of cancer 10 years after treatment compared to those who don't receive the boost dose.
   Similar news · Read more »
   
9. Other patients bear the real cost of Herceptin
   11-23-2006 · EurekAlert!
   The real cost of Herceptin is born by other patients whose treatment has to be dropped to balance the books, say doctors in this week’s BMJ.New guidance from the National Institute for health and Clinical Excellence (NICE) recommends trastuzumab (Herceptin) in early breast cancer, but it provides no extra funding and does not suggest what cuts should be made to release this extra money. This leaves medical staff with difficult decisions to make.
   Similar news · Read more »
   
10. Improved imaging for identifying breast cancer in overweight women
    02-06-2007 · EurekAlert!
    Increasing the ability to identify sentinel nodes -- the very first lymph nodes that trap cancer cells draining away from a breast lesion site -- has a major impact in the treatment and outcome of breast cancer patients, possibly eliminating the need for unnecessary and painful surgery. Researchers found that using SPECT/CT imaging aids in sentinel node identification -- especially for overweight or obese women, according to a report in the February issue of the Journal of Nuclear Medicine.
    Similar news · Read more »